2 Post-doc positions in Cat4Cancer

Updated: 3 months ago
Deadline: 26 May 2024

29 Nov 2023
Job Information
Organisation/Company

University of Amsterdam (UvA)
Research Field

Physics
Researcher Profile

Recognised Researcher (R2)
Country

Netherlands
Application Deadline

26 May 2024 - 13:17 (UTC)
Type of Contract

Temporary
Job Status

Not Applicable
Hours Per Week

38.0
Is the job funded through the EU Research Framework Programme?

Not funded by an EU programme
Is the Job related to staff position within a Research Infrastructure?

No

Offer Description

The Van 't Hoff Institute for Molecular Sciences (HIMS) is one of eight institutes of the Faculty of Science of the University of Amsterdam. (UvA). HIMS performs internationally recognized research in molecular sciences, both curiosity as well as application driven. This is partly done in cooperation with the chemical, energy, flavour & food, medical and high-tech industries.Within the Synthesis and catalysis cluster, the Homogeneous, Supramolecular and Bio-Inspired Catalysis (HomKat) group is looking for two post-docs. These post-docs will perform their research in the laboratory of the HOMKAT group in collaboration with University of Leiden (prof Kros) and NKI (cancer institute, dr Akkari) in the context of catalysis for cancer program.

Cat4cancer program
Every year in the Netherlands some 500 to 700 people are diagnosed with glioblastoma. Neither surgery, radiotherapy, nor chemotherapy have yet provided a cure for this form of brain cancer. The challenge faced by surgical and radiotherapy teams is that the tumours are not sharply defined and invade deep into the surrounding brain tissue.

The challenge for drug-based therapy is that glioblastoma cells are very effective in developing resistance. Even novel immunotherapy approaches – which have proved impressively successful in other solid tumours – have failed in the case of glioblastoma. This is largely due to a highly suppressive tumour microenvironment, where the so-called tumour-associated macrophages effectively ‘hijack’ the local immune response. In search of a solution, the Cat4CanCenter project takes a radically new approach. It combines the efforts of Prof. Joost Reek, an expert in catalysis at the UvA, Prof. Alexander Kros of Leiden University, specialising in drug delivery, and Dr Leila Akkari, a cancer immunologist at the Netherlands Cancer Institute (NKI) and Oncode Institute. Together, they propose a pioneering form of chemotherapy where active, toxic drugs are synthesised in the tumour environment itself. To enable this, first a molecular catalyst is delivered into the tumour tissue using lipid nanoparticles. Next, so-called pro-drug molecules are administered. Finally, the catalyst converts these non-toxic precursors into active drugs that will fight the glioblastoma ‘from within’.

In the context of this large program, the Homkat group currently has two post-doc positions available to design caged catalysts that will perform the synthesis of the desired drug molecules. In recent years the Homkat team has developed caged catalysts that allow metal-catalyzed synthesis in a biological environment. They now function in an aqueous environment, in the presence of biological molecules and even in living cells. By designing the cage so that is has affinity for the prodrug, we can make the catalyst operate in an enzyme-like fashion, boosting the conversion efficiency at low concentrations. In this program we need to make sure we can synthesise a whole range of drug molecules to combat all aspects of glioblastoma rapid growth, which involves the development of a large toolbox of caged catalysts for a variety of transformations. The research will be performed in close collaborations with the projects that are developed in Leiden and at NKI in the context of the ERC synergy program cat4cancer. https://hims.uva.nl/content/news/2023/10/ €10.6-million-for-innovative-toolboxes-to-tackle-brain-cancer.html.


Requirements
Specific Requirements

You should be a creative thinker that likes challenging projects. You preferable have a background in synthesis and catalysis, with affinity for supramolecular chemistry, biochemistry/biology. You should be team players as the projects will be carried out in the context of the larger collaborative program.You will be appointed at the University of Amsterdam (UvA).

A PhD degree in chemistry with a substantial experimental synthetic chemistry is required. The ability to collaborate and adapt in an international team is required and candidates must possess good communication skills in oral and written English. Due to limitations in recruitment budget we will preferably consider candidates that are currently in Europe. The positions are open till be found the proper candidates.


Additional Information
Benefits

A temporary contract for 38 hours per week, preferably starting on the 1st of January, 2024, for the duration of 12 months. An extention may be possible based on available funding combined with adequate performance.

The gross monthly salary, based on 38 hours per week and dependent on relevant experience, ranges between €3,226 - € 5,090 (scale 10). This does not include 8% holiday allowance and 8,3% year-end allowance. The UFO profile Researcher 4 is applicable. A favourable tax agreement, the ‘30% ruling’, may apply to non-Dutch applicants. The Collective Labour Agreement of Dutch Universities is applicable.

Besides the salary and a vibrant and challenging environment at Science Park we offer you multiple fringe benefits:

  • 232 holiday hours per year (based on fulltime) and extra holidays between Christmas and 1 January;
  • Multiple courses to follow from our Teaching and Learning Centre;
  • Multiple courses on topics such as leadership for academic staff;
  • Multiple courses on topics such as time management, handling stress and an online learning platform with 100+ different courses;
  • 7 weeks birth leave (partner leave) with 100% salary;
  • Partly paid parental leave;
  • The possibility to set up a workplace at home;
  • A pension at ABP for which UvA pays two third part of the contribution;
  • The possibility to follow courses to learn Dutch;

Are you curious to read more about our extensive package of secondary employment benefits, take a look here .


Selection process

The UvA is an equal-opportunity employer. We prioritise diversity and are committed to creating an inclusive environment for everyone. We value a spirit of enquiry and perseverance, provide the space to keep asking questions, and promote a culture of curiosity and creativity.

Do you recognize yourself in the job profile? Then we look forward to receiving your application by January 1, 2024 at latest. You may apply online by using the link below.

Applications in .pdf should include:

  • A curriculum vitae including the list of publications (please put in the months and not just years when referring to your education and work experience);
  • A letter of motivation (max 1 page A4);
  • A reference (email, phone number) to the direct supervisor in the previous academic position.

We will recruit until the positions are filled. The selection process commences immediately, but will close when a suitable candidate has been found, even if this is prior to the final date of the application window.
Any other correspondence in response to this advertisement will not be dealt with.


Additional comments

Do you have any questions or do you require additional information? Please contact:

  • Prof.J.N.H. (Joost) Reek , Professor

Website for additional job details

https://www.academictransfer.com/335060/

Work Location(s)
Number of offers available
1
Company/Institute
Faculty of Science
Country
Netherlands
City
Amsterdam
Postal Code
1098XH
Street
Science Park 904

Where to apply
Website

https://www.academictransfer.com/en/335060/2-post-doc-positions-in-cat4cancer/a…

Contact
City

Amsterdam
Website

http://www.uva.nl/
Street

Spui 21
Postal Code

1012 WX

STATUS: EXPIRED

Similar Positions